REPORT ID 1345

EMEA (Europe, Middle East and Africa) Cardiovascular Disease Diagnostics Market Report 2017

Publish Date
05-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Cardiovascular Disease Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cardiovascular Disease Diagnostics for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cardiovascular Disease Diagnostics market competition by top manufacturers/players, with Cardiovascular Disease Diagnostics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Diagnostics
    Alere Inc.
    Beckman Coulter, Inc.
    Cholestech Corp.
    GE HealthCare
    Nanogen Inc.
    Philips Medical Systems
    Roche Diagnostics
    Siemens Healthcare Diagnostics Inc.
    St Jude Medical Inc.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    In Vitro Diagnostics
    In Vivo Diagnostics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Cardiovascular Disease Diagnostics for each application, including
    Hospital
    Clinic
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Cardiovascular Disease Diagnostics Market Report 2017
1 Cardiovascular Disease Diagnostics Overview
    1.1 Product Overview and Scope of Cardiovascular Disease Diagnostics
    1.2 Classification of Cardiovascular Disease Diagnostics
        1.2.1 EMEA Cardiovascular Disease Diagnostics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Cardiovascular Disease Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 In Vitro Diagnostics
        1.2.4 In Vivo Diagnostics
    1.3 EMEA Cardiovascular Disease Diagnostics Market by Application/End Users
        1.3.1 EMEA Cardiovascular Disease Diagnostics Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 EMEA Cardiovascular Disease Diagnostics Market by Region
        1.4.1 EMEA Cardiovascular Disease Diagnostics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Cardiovascular Disease Diagnostics (2012-2022)
        1.5.1 EMEA Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Cardiovascular Disease Diagnostics Revenue and Growth Rate (2012-2022)

2 EMEA Cardiovascular Disease Diagnostics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Cardiovascular Disease Diagnostics Market Competition by Players/Manufacturers
        2.1.1 EMEA Cardiovascular Disease Diagnostics Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Cardiovascular Disease Diagnostics Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Cardiovascular Disease Diagnostics Sale Price by Players (2012-2017)
    2.2 EMEA Cardiovascular Disease Diagnostics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Cardiovascular Disease Diagnostics Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Cardiovascular Disease Diagnostics Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Cardiovascular Disease Diagnostics Sale Price by Type (2012-2017)
    2.3 EMEA Cardiovascular Disease Diagnostics (Volume) by Application
    2.4 EMEA Cardiovascular Disease Diagnostics (Volume and Value) by Region
        2.4.1 EMEA Cardiovascular Disease Diagnostics Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Cardiovascular Disease Diagnostics Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Cardiovascular Disease Diagnostics Sales Price by Region (2012-2017)

3 Europe Cardiovascular Disease Diagnostics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Cardiovascular Disease Diagnostics Sales and Value (2012-2017)
        3.1.1 Europe Cardiovascular Disease Diagnostics Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Cardiovascular Disease Diagnostics Revenue and Growth Rate (2012-2017)
    3.2 Europe Cardiovascular Disease Diagnostics Sales and Market Share by Type
    3.3 Europe Cardiovascular Disease Diagnostics Sales and Market Share by Application
    3.4 Europe Cardiovascular Disease Diagnostics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Cardiovascular Disease Diagnostics Sales Volume by Countries (2012-2017)
        3.4.2 Europe Cardiovascular Disease Diagnostics Revenue by Countries (2012-2017)
        3.4.3 Germany Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        3.4.4 France Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        3.4.5 UK Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        3.4.6 Russia Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        3.4.7 Italy Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)

4 Middle East Cardiovascular Disease Diagnostics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Cardiovascular Disease Diagnostics Sales and Value (2012-2017)
        4.1.1 Middle East Cardiovascular Disease Diagnostics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Cardiovascular Disease Diagnostics Revenue and Growth Rate (2012-2017)
    4.2 Middle East Cardiovascular Disease Diagnostics Sales and Market Share by Type
    4.3 Middle East Cardiovascular Disease Diagnostics Sales and Market Share by Application
    4.4 Middle East Cardiovascular Disease Diagnostics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Cardiovascular Disease Diagnostics Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Cardiovascular Disease Diagnostics Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        4.4.4 Israel Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        4.4.5 UAE Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        4.4.6 Iran Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)

5 Africa Cardiovascular Disease Diagnostics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Cardiovascular Disease Diagnostics Sales and Value (2012-2017)
        5.1.1 Africa Cardiovascular Disease Diagnostics Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Cardiovascular Disease Diagnostics Revenue and Growth Rate (2012-2017)
    5.2 Africa Cardiovascular Disease Diagnostics Sales and Market Share by Type
    5.3 Africa Cardiovascular Disease Diagnostics Sales and Market Share by Application
    5.4 Africa Cardiovascular Disease Diagnostics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Cardiovascular Disease Diagnostics Sales Volume by Countries (2012-2017)
        5.4.2 Africa Cardiovascular Disease Diagnostics Revenue by Countries (2012-2017)
        5.4.3 South Africa Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Cardiovascular Disease Diagnostics Sales and Growth Rate (2012-2017)

6 EMEA Cardiovascular Disease Diagnostics Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Diagnostics
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Diagnostics Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Alere Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Alere Inc. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Beckman Coulter, Inc.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Beckman Coulter, Inc. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cholestech Corp.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cholestech Corp. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GE HealthCare
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GE HealthCare Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Nanogen Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Nanogen Inc. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Philips Medical Systems
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Philips Medical Systems Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Roche Diagnostics
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Roche Diagnostics Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Siemens Healthcare Diagnostics Inc.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Siemens Healthcare Diagnostics Inc. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 St Jude Medical Inc.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Cardiovascular Disease Diagnostics Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 St Jude Medical Inc. Cardiovascular Disease Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Cardiovascular Disease Diagnostics Manufacturing Cost Analysis
    7.1 Cardiovascular Disease Diagnostics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cardiovascular Disease Diagnostics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cardiovascular Disease Diagnostics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cardiovascular Disease Diagnostics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Cardiovascular Disease Diagnostics Market Forecast (2017-2022)
    11.1 EMEA Cardiovascular Disease Diagnostics Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Cardiovascular Disease Diagnostics Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Cardiovascular Disease Diagnostics Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Cardiovascular Disease Diagnostics Price and Trend Forecast (2017-2022)
    11.2 EMEA Cardiovascular Disease Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Cardiovascular Disease Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Cardiovascular Disease Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Cardiovascular Disease Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Cardiovascular Disease Diagnostics Sales Forecast by Type (2017-2022)
    11.7 EMEA Cardiovascular Disease Diagnostics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer